The Medical Device Business Journal — Medical Device News & Articles | MassDevice

The FDA has granted Royal Philips (NYSE:PHG) an emergency use authorization for one of its IntelliVue bedside patient monitors remotely to reduce healthcare provider exposure to COVID-19.

The authorization allows providers to use IntelliVue MX750 bedside monitors outside of patient rooms. The monitors can be used to acquire multiple physiological patient signals, including remote display of measurement values, waves and trends, according to the FDA.

They can also generate physiological and technical alarms, provide data recording, and support patient data management without requiring healthcare providers contact with the patient, the agency said.

Shares of PHG ticked up 1.52% to $43.49 in mid-morning trading today after Monday’s news of a major profit slide for the first quarter of 2020 due to the coronavirus pandemic.

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Patient Monitoring, Regulatory/Compliance Tagged With: coronavirus, COVID-19, FDA, Philips

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.